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Abstract: 
  
Aim:  
Our objectives were to compare people with epilepsy (PWE) who died of Sudden Unexpected Death in Epilepsy 
(SUDEP) with live controls using the risk factor items of the SUDEP and Seizure Safety Checklist.  
Method: 
All 48 SUDEPs of 93 epilepsy deaths which occurred in Cornwall UK 2004-2012 were compared to 220 live controls 
using the SUDEP and Seizure Safety Checklist, an evidenced based tool used to communicate person centred risk of 
SUDEP to PWE. The odds ratio for having a specific factor in those who died was compared to controls and ranked 
according to P value using a sequential Bonferroni correction for multiple comparisons.  
Result:  
Of the 17 modifiable and non- modifiable risk factors analysed 9 were statistically significant of which 7 are potentially 
modifiable. Well known modifiable factors such as nocturnal monitoring, compliance and sleeping position featured 
prominently in the risk association. 
Conclusion: 
This is the 1st case control study exploring the risk factors for SUDEP since 2009. The findings are compared to the 
current considered risk factors as identified in a major recent review.  The study further validates certain SUDEP risk 
factors. It highlights that the majority of risk factors strongly associated with SUDEP are potentially modifiable. There 
is an emerging profile to rank the risk factors. It furthers the evidence to use structured risk assessment and 
communication tools such as the SUDEP and Seizure Safety Checklist in daily clinical practice. It highlights key areas 
for a person centred discussion to empower PWE to mitigate risk.  
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
  
Sudden unexpected death in epilepsy (SUDEP) is the most important direct cause of deaths in epilepsy1. People with 
epilepsy (PWE) are 20 times more likely to die suddenly compared to the general population2. SUDEP is the most 
common cause of death in PWE. In the UK in 2013, 1187 people died from epilepsy (includes SUDEP, Status etc.) , 
roughly the same amount of that died from asthma (1255) despite there being a population of over 5.3 Million people 
with asthma while PWE number around 600,000. The 2013 Office of National Statistics UK data suggest that up to 
60.5% of these epilepsy deaths were seen as avoidable whereas 25.5% of asthma deaths were.  This suggests that there 
may be improvement in the way we identify risk and manage PWE in the community. 
 
In a recent literature review on risk factors for SUDEP3, twenty factors were identified that increased the risk of 
SUDEP. These 20 factors were subsequently applied to a previously unexposed set of all SUDEPs (n=48) extracted by 
going through all epilepsy deaths (n=93) in the county of Cornwall UK (population 550,000) between 2004 -2012 to see 
if they remained consistent with the literature review findings4. It was found that 17 factors remained well associated 
with SUDEP and are directly relevant for people living with epilepsy. These 17 factors forms the background of the 
Seizure and SUDEP safety checklist, a 10 minute risk assessment tool used in epilepsy clinics across UK and the self-
monitoring of epilepsy risk mobile app EpSMon5, 6, 7.  We compared these 17 factors between the 48 subjects who died 
from SUDEP in Cornwall with 220 of 231 continuous patients living with epilepsy who attended local outpatient 
epilepsy clinics to determine how strongly these factors are associated with SUDEP risk in a well defined population. 
 
Method 
We compared data collected over 9 continuous years of SUDEPs at the Cornwall Coroner’s office using the SUDEP 
and Seizure Safety Checklist3, 4 with data from medical records of clinical discussion with a full year of most PWE 
attending local epilepsy outpatient clinics on the potential risk factors identified for SUDEP using the same checklist.  
 
We systemically inspected all epilepsy and epilepsy associated deaths which occurred in Cornwall between 2004 and 
2012 all made available to us by the HM Cornwall coroner. These are the deaths where epilepsy was a primary or a 
secondary cause. The Cornwall coroner’s office has a computerized system with a search engine to explore all 
registered death certificates. The data were collected from the coroner’s records using the terms ‘ep’, ‘epilepsy’, 
‘Seizures’, ‘fits’, ’Sudden death’ and  ‘SUDEP’ in either part 1 or 2 of the death certificate. Ninety three deaths were 
thus identified by the coroner’s office. Each death’s case file which included all comprehensive medical records up to 
the point of death was reviewed to ascertain those deaths which met the SUDEP criteria and classification using the 
operational definition of SUDEP provided by Nashef and Anneger 4, 8. Of the 93 cases of epilepsy related deaths which 
occurred in Cornwall between 2004 and 2012. Forty eight cases met the criteria for SUDEP.  We cross-referenced the 
  
epilepsy deaths of these years (2004-2012) with public health data on epilepsy deaths held by the Public Health 
Department of Cornwall and the Isles of Scilly Primary Care Trust. The public health data showed 73 epilepsy deaths 
(43 male and 30 females) for the period of 2006 -2012. This is in keeping with our estimates for that period. The public 
health data only had the year, number of deaths and sex recorded. We then applied the clinical risk factors of the 
SUDEP and Seizure safety Checklist to all the SUDEP deaths. The detailed definitions used for the risk factors are 
described in previous papers3,4,6  and table 1. 
 
The control population  attended two specialist epilepsy outpatient clinics in Cornwall and for whom the Seizure safety 
and SUDEP checklist3, 5, 6, 7 was administered as part of routine clinical practice over one year. The population was a 
continuous sample.  Of 231 attendees in the one year  (05/2013- 05/2014) to the two clinics 220 consented to the use of 
the Checklist. One year was chosen in order to sample the whole clinic population (maximum follow up time is one 
year). 
 
We calculated the odds ratio for having a specific factor in those who died from SUDEP compared to controls. We 
ranked the factors according to P value and used a sequential Bonferroni to correct for multiple comparisons. Low 
numbers and missing data prevented a logistic regression analysis. 
 
Results 
The United Kingdom (UK) has a population of about 60 million. Cornwall is a county in UK with a population of 
600,000 (about 1% of the UK population). It is largely a rural county and not subject to major immigration/emigration 
(except for large number of tourists during summer). The incidence of SUDEP has been estimated as 0.1% of all people 
diagnosed with epilepsy per year though it can raise to 1 in 150 PWE in refractory cases. An estimated 600 deaths occur 
in a year due to SUDEP in the UK and thus Cornwall would be expected to have approximately 6 SUDEP deaths a year. 
Our study is consistent with these numbers as 48 deaths over 9 years represent a rate of 5.33 SUDEP deaths/ year. 
 
Our case sample was 48 people, 33 male and 15 female who died from SUDEP in Cornwall UK over the 9 year period4.  
Among the 48 deaths, the mean age was 42.5 years and median 42 years with a range of 2-82 years. Our control sample 
was 220 outpatients attending epilepsy clinics within Cornwall of whom 115 were male and 105 female. Among the 
220 people, the mean age was 42.76 years and median 47.5 years with a range of 9-86 years. The majority of the 
SUDEP cases had been known to the local specialist epilepsy services sometime in their lifetime. However 80% of the 
SUDEP cases did not see a specialist in the year prior to death.  
 
  
The comparison between the groups is given in Table 1 and illustrated in Figure 1. Of the 17 risk factors, 9 showed a 
significant difference between the two groups. Two significant risk factors - duration of epilepsy and diagnosis of 
generalised tonic clonic epilepsy – are not modifiable. However, there were seven potentially modifiable risk factors: 
unclear treatment history, poor adherence to medication, sub-therapeutic medication levels, alcohol misuse, no night 
surveillance, sleeping in the prone position and increasing seizure frequency, which could be ranked. 
 
Conclusion 
This is the first case control study exploring the risk factors for SUDEP since 2009. There were four major case control 
studies looking at SUDEP risk factors9, 10,11,12,13 whose data was pooled and a combined analysis of the identified risk 
factors conducted in 20119.  Our study supports many of the pooled findings from those studies that certain factors have 
a considerable impact upon the risk of SUDEP, and importantly, a large proportion of these factors can be modified. 
Some factors considered are new or are bearing different results to the pooled analysis. This study finding has been 
compared to the current evidence of a recent major review on SUDEP risk factors (table 2). 
The 4 case control studies 10,11,12,13 while all trying to enumerate risk factors were diverse in their design, examination of 
population of risk and controls (table 3). Risk factor examination was more explorative in nature. The pooled analysis 9 
was a function of the results of these studies. Our study unlike other SUDEP case control studies had a pre-designed 
questionnaire which had the advantage of having extracted the risk factors of all the other studies in particular the 
pooled analysis 9 and re-testing it in a new population thus looking to see if the factors identified by the pooled analysis 
were generally applicable. The pooled analysis got its data from studies of different geographic regions and 
demographics.  The current study observed if such a pooled result could be representative in a new region with a well-
defined population.  
There are other advantages to our study too.  Three of the four past studies 10, 12, 13 were hospital centric with the deaths 
being traced from hospital records and not community based. One of the four studies11 collected referrals from diverse 
streams but was not structured to identify the full population at risk and thus not systematic. Our study has the 
advantage that controls and SUDEP were drawn from the same population. Moreover, it is also the only study where a 
pre-developed checklist has been used in both the people who died and controls..  
 
Poor accessibility of services or poor engagement with services as indicated by an unclear treatment history, poor 
adherence, increasing seizure frequency and sub-therapeutic medication levels increased the risk of being in the SUDEP 
group. As previously found if patients misuse alcohol they add to their risk of SUDEP. If patients have night 
surveillance through someone sleeping with them or using a monitor, risk is reduced, as is sleeping in the non-prone 
position. While the association of the ‘prone position’ is strong and theoretically a modifiable risk factor the actual and 
  
practical modifiability of this factor is contested.  People don't typically stay just prone in bed while sleeping they toss 
and turn. Patients with epilepsy typically roll over when having seizures to turn their face into the pillow. There might 
be a role for anti-asphyxia pillows 14. Night surveillance, while a practically achievable issue, should take into account 
privacy issues and the choice to live alone. A practical person-centred approach to such social situations might pay 
dividends. All of these factors can be addressed but require the patient to be informed about SUDEP risks (an aim of the 
SUDEP checklist). 
 
As with the combined analysis9 carbamazepine as a risk factor was not significant thus further consolidating its safety 
profile with regard to SUDEP. Interestingly being male and taking antidepressants were not significant; this may have 
been the result of an underpowered study but it does indicate that these factors are probably not so critical. 
 
The negative finding on intellectual disability (ID) is difficult to interpret. Other studies have shown this to be a risk 
factor of SUDEP9, 10, , 15, 16. However Cornwall has a dedicated ID epilepsy service as approximately 25% of PWE have 
ID and our data suggest only 6.3% of people dying from SUDEP have an ID4 compared to 23.4% in other studies15. It is 
possible that ID as a risk factor is dependent on the quality of services rather than the ID itself. 
 
There are clear limitations to this study. The cases of people dying from SUDEP were taken over 9 years between 2004 
and 2012. The controls were patients attending specialist clinics between 2012 and 2014. However the management of 
epilepsy has not changed radically over this period as reflected in the similar NICE guidelines for the management of 
epilepsy published in 2004 and 2012. The 1st line drugs and many other strategies for managing seizures remain pretty 
much the same. Inspite of being proposed as a NICE guidance since 2004 the communication of the risk of SUDEP has 
been significantly low in fact 4% in 201317.  Both the 2001 and 2011 national census confirms Cornwall is one of the 
poorest parts of the United Kingdom in terms of per capita GDP and average household incomes. They also reveal 
social deprivation, ethnicity and migration rates (very low) have not changed substantially. In fact the same epilepsy 
teams and personnel have been in place managing this same population of PWE which has a low turnover.  While all 
the controls were from specialist clinics it is worth noting that the highest risk patients were being compared.  It can be 
thus argued that the impact of the potential bias of the various limitations emerging from the control group selection is 
minimal.  
 
Given that sub-therapeutic drug levels may be a reflection of medication nonadherence, the two are by no means 
independent of each other. The same is true for early onset of epilepsy” and prolonged (>15 years) duration of epilepsy 
  
not necessarily mutually exclusive. Unfortunately, given low numbers and missing data a logistic regression analysis 
could not be performed.  
 
The cases and controls were not matched samples. The review of medical notes was not blind to the reviewers which 
may be a source of bias, and the controls were determined from an outpatient clinic. However this is the first study 
where a structured application of a predesigned risk checklist to both the demised PWE and controls has been done. 
Both sets were also were drawn from the same at risk epidemiological population i.e. county of Cornwall (population 
550,000) UK. This has provided an opportunity to rank the risk factors thus highlighting that SUDEP is not only 
modifiable and multi-dimensional but likely to be associated with different intensity and degrees of risk. It again 
highlights that SUDEP could be a cumulative effect of few or many of these risk factors, many modifiable and possibly 
coming together in a ‘perfect storm’ to cause an adverse outcome. There were 2 children under 15 in the study. Some 
factors would not apply to children and others might be less modifiable. Given the small numbers we do not believe it 
would have influenced the outcome of our study.  
 
Overall, our study supports the use of an evidenced based checklist in order to discuss potentially modifiable factors 
with patients, especially those people at a high risk of SUDEP. Cornwall Public Health and coroner annual data show 
SUDEP deaths have reduced considerably in the last 2 years compared to previous years, though given the small 
numbers involved and the multiple variables these at best are early trends. It sits well with the fact that of PWE and/or 
their carers administered the Checklist in the last 3 years in epilepsy clinics (n=400+) in Cornwall UK, 98% of patients 
approved, felt empowered and felt safer knowing person-centred risk5.6. There is anecdotal evidence to suggest it 
contributed to improved compliance and adherence of  medication and more importantly contact with health services if 
problems existed with the medication as opposed to generally stopping it without advice.  A structured approach may 
pay dividends in focusing individuals on items in their locus of control and may mitigate risk.  
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Table 1 Univariate analysis 
Rank Factor and its description Odds ratio   95%CI P value 
1 Sleeping in prone position 
Independent risk factor evidenced by 
several studies including a systematic 
review. 
The prone position is defined as lying 
on the belly, chest, or face, with or 
without obstruction of the nose or 
mouth.  Sleeping in the prone position 
or remaining in a prone position post 
seizure is considered a risk. 
0.034 0.012, 0.094 <0.001* 
2 Treatment History – unclear 
This is defined as where the rationale 
for treatment in the last 6 months is 
not supported by current clinical 
evidence base such as NICE. For 
example not modifying AED treatment 
if someone has refractory epilepsy 
or not considering referring to a 
comprehensive epilepsy center for a 
surgical evaluation. 
0.03 0.01, 0.1 <0.001* 
3 Generalised tonic clonic epilepsy 
Combined data from the previous four 
case-control studies found this is the 
most important risk factor 
0.03 0.01, 0.09 <0.001* 
4 Increasing seizure frequency 
Active Seizures which in the last 6 
0.05 0.02, 0.14 <0.001* 
  
months were noted to worsen in 
frequency of > 25%  
5 Compliance issues 
This factor is defined by finding of 
variable AED hair strand levels in 
SUDEP group. Compliance issues 
were also assessed via patient 
reporting as evidenced by medical 
records in both groups. Adherence 
issues (including not picking up 
prescriptions) found as a factor across 
all epilepsy-related deaths as 
increasing risk by 50% 
0.09 0.03, 0.23 <0.001* 
6 Alcohol problem 
Is defined as where there is a clinically 
definable alcohol disorder as identified 
by the WHO ICD 10 diagnostic 
Manuel. A systematic analysis of 
epilepsy deaths confirmed this risk 
factor. 
0.10 0.04, 0.28 <0.001* 
7 Sub therapeutic AED levels 
Is a finding linked closely to 
compliance 
0.08 0.025, 0.24 <0.001* 
8 Night surveillance 
Nocturnal Seizures were shown to 
have a 4 fold increased risk. 60% of all 
SUDEPs in large control study. 
Nocturnal surveillance thus where 
present is considered to be a protective 
13.0 3.7, 45.26 <0.001* 
  
factor. 
9 Duration (>15 years) 
This has been suggested by several 
studies, but not after multiple logistical 
regression analysis for seizure 
frequency 
0.22 0.10, 0.49 <0.001* 
10 Early onset epilepsy 
Where the onset of epilepsy is before 
the age of 15 years 
0.40 0.18, 0.90 0.025 
11 Frequent AED changes 
This is defined as where the changes 
of dose or medication were not 
following British National Formulary 
(BNF) guidance on titration in the last 
6 months. 
0.3 0.10, 0.92 0.035 
12 Presence of anxiolytic  medication 
This is defined as having ‘anxiolytic 
medication’ as defined by BNF 4.1.2 
Currently it is unclear how relevant a 
risk factor this is as it has not been 
clearly defined.  
0.41 0.16, 1.05 0.06 
13 Intellectual Disability (ID) 
2 case–control studies found ID to be a 
risk factor whereas 2 others did not.  In 
the combined analysis ID was not a 
significant risk factor The incidence of 
SUDEP was higher 
among children with “complicated” 
epilepsy 
2.5 0.66, 9.34 0.18 
  
(with known structural brain lesion, 
intellectual disability) than those 
without. Concerns exist on the way ID 
is described and cases collected. 
14 Male Gender 
Was found a risk factor commonly in 
descriptive studies but has not been 
replicated in controlled studies. 
0.62 0.29, 1.31 0.21 
15 Depression treatment 
This is defined as having clinical 
depression as per ICD 10 /DSMV 
and/or being on antidepressant 
medication’ as defined by BNF 4.3 
and/or having therapy/counseling for 
depression. 
Currently it is unclear how relevant a 
risk or a safety factor depression or its 
treatment particularly SSRIs are. This 
is has not been clearly defined. 
0.74 0.31, 1.80 0.50 
16 Carbamazepine 
there is no significant association 
between use of 
 carbamazepine and SUDEP risk as 
per current evidence 
1.10 0.51,2.32 0.83 
17 Increasing seizure severity 
This is evidenced by an increase in the 
last 6 months of the  administration of 
rescue medication such as Midazolam, 
paramedic call outs or ED visits as 
recorded in clinical notes 
0.94 0.26, 3.40 0.92 
 
  
  
Factors are ranked by P value. * indicates significant using a sequential Bonferroni correction for multiple comparisons 
with alpha = 0.05 
 
Figure 1: Odds ratios for having SUDEP given risk factor. Bars represent 95% CI. Solid circles are significant factors 
after sequential Bonferroni correction. 
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Table 2:  
Comparison between identified risk factors in the study and recently published review of risk factors for SUDEP 
Risk Factor  Shankar et al findings  Tomson et al 201617 review of risk 
factors  
Sleeping in prone position Significant A risk factor requires more 
confirmation 
Treatment History – unclear Significant Not considered in review 
Generalised tonic clonic epilepsy Significant Strong risk factor 
Increasing seizure frequency Significant A risk factor 
Compliance issues Significant Possible risk factor 
Alcohol problem Significant Possible risk factor 
Sub therapeutic AED levels Significant Unreliable as a risk factor 
Night surveillance Significant A risk factor but requires more 
confirmation 
Duration (>15 years) Significant A risk factor 
Early onset epilepsy Close to significant – power 
might play a role 
A risk factor 
Frequent AED changes Close to significant – power 
may play a role 
Not considered in review 
Presence of anxiolytic  medication Close to significant –power 
may play a role 
Not considered in review 
Intellectual Disability (ID) Not significant – confounder 
recognized 
Conflicting evidence on risk factor. 
Require more studies. 
Male Gender Not significant A risk factor 
Depression treatment Not significant Not considered in review 
Carbamazepine Not Significant Not a risk factor 
Increasing seizure severity Not Significant Not considered in review 
 
 
 
 
  
Table 3: 
 U.S. Study10 Swedish Study13 Scottish Study12 English Study 11 Our Study 
Rough Time 
period of 
Study 
1991 -1996 1980-1989 From 1982 all 
deaths till near 
the study (2007) 
1989-1998 2004 -2012 
Case to 
controls mix 
20 cases and 
80 controls 
56 cases and 157 
controls 
64 cases and 119 
controls 
149 cases and 
602 controls 
48 cases and 
220 controls 
Case 
description 
SUDEP in 
specialist 
epilepsy 
centres 
Discharged from 
hospitals diagnosis 
of epilepsy on 
death certificates 
Those registered 
with the epilepsy 
unit 
SUDEP were 
identified by 
coroners, 
neurologists, self-
referred by family 
members, and by 
the charity 
Epilepsy 
Bereaved 
SUDEP in 
community 
and being 
representative 
of all deaths in 
Cornwall UK 
(pop: 600,000) 
Case 
specifics 
 Identified deaths 
between 15-70 
years 
 16-50 years No age limit 
Control 
description 
Controls 
randomly 
selected 
For each case of 
SUDEP 3 living 
controls were 
randomly drawn 
from the study 
population and 
matched on year of 
birth, sex, and 
assessment period. 
2 living controls 
were randomly 
selected from the 
Epilepsy Unit 
population and 
matched on year 
of birth, gender, 
and syndrome 
classification 
4 controls with 
epilepsy were 
randomly selected 
from a diagnostic 
index and a 
prescription 
database and 
matched to each 
SUDEP case 
according to age 
and geographic 
location. 
The control 
population 
attended two 
specialist 
epilepsy 
outpatient 
clinics in 
Cornwall. The 
population was 
a continuous 
sample.   
 
